1Krieger JNK, Riley DE. Bacteria in the chronic prostatitis/ehronie pelvic pain syndrome: mo- lecular approaches to critical research ques- tions. J Urol, 2002,167 ( 6 ) : 2574 - 2583. 被引量：1
2Rowe E, Smith C, Laveriek L, et al. A prospec- tive, randomized, placebo controlled, double - blind study of pelvic electromagnetic therapy for the treatment of chronic pelvic pain syn- drome with 1 year of followup. J Urol, 2005, 173(6) :2044 -2047. 被引量：1
1[1]Barbalias GA, Nikiforidis G, Liatsikos EN. α-Blockers for the treatment of chronic prostatitis in combination with antibiotics[J]. J Urol, 1998,159(3):883～887. 被引量：1
2[2]Nickel JC, Nyberg LM, Hennenfent M. Research guidelines for chronic prostatitis: consensus report from the first National Institutes of Health International Prostatitis Collaborative Network [J]. Urology,1999,54(2):229～233. 被引量：1
3[3]Nickel JC.Effective office management of chronic prostatitis [J].Urol Clin North Am, 1998,25(4):667～684. 被引量：1
4[4]Litwin MS, McNaughton Collins M, Fowler FJ Jr, et al. The national institutes of health chronic prostatitis symptom index: development and validation of a new outcome measure chronic prostatitis collaborative research network[J]. J Urol, 1999,162(2):369～ 375. 被引量：1
5[5]Theodorou C, Konidaris D, Moutzouris G, et al. The urodynamic profile of prostatodynia [J]. BJU Int, 1999,84(4):461～463. 被引量：1
6[6]Barbalias GA. Clinical and theraputical guidelines for chronic prostatitis [J]. Eur Urol,2000,37(1):116～117. 被引量：1
7[7]Neal DE Jr, Moon TD. Use of terazosin in prostatodynia and validation of a symptom score questionnaire [J]. Urology, 1994,43(4):460～465. 被引量：1
8[8]Price DT, Schwinn DA, Lomasney JW,et al. Identification, quantification, and localization of mRNA for three distinct alpha1 adrenergic receptor subtypes in human prostate [J]. J Urol, 1993,150(4):545～551. 被引量：1
